Ignite Creation Date:
2024-07-17 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499285
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-05
Brief Title:
The Efficacy and Safety of Elritercept in Adult Participants With Very Low Low or Intermediate Risk Myelodysplastic Syndromes MDS With Anemia RENEW
Sponsor:
Keros Therapeutics Inc
Organization:
Keros Therapeutics Inc
Organization Data
Organization:
Keros Therapeutics Inc
Class:
INDUSTRY
Study ID:
KER-050-D301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Keros Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None